Investigation into Breaches of Fiduciary Duties by Directors and Officers of Edwards Lifesciences Corporation

Rosen Law Firm is investigating potential breaches of fiduciary duties by directors and officers of Edwards Lifesciences Corporation. Investors who own Edwards stock can visit the firm's website at https://rosenlegal.com/submit-form/?case_id=29704 for more information. The Rosen Law Firm represents investors globally and has a track record of success in securities class actions and shareholder derivative litigation.

Rosen Law Firm, a renowned global investor rights law firm, has initiated an investigation into potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW). The firm, known for its expertise in securities class actions and shareholder derivative litigation, is urging investors to take action if they suspect wrongdoing.

Investors currently holding Edwards stock are advised to visit the Rosen Law Firm's website at https://rosenlegal.com/submit-form/?case_id=29704 for more information on the investigation. They can also contact Phillip Kim of Rosen Law Firm toll-free at 866-767-3653 or via email at case@rosenlegal.com.

The Rosen Law Firm has a proven track record of success, having secured hundreds of millions of dollars for investors in various securities class action settlements. In 2019 alone, the firm secured over $438 million for investors. The firm's founding partner, Laurence Rosen, was named a Titan of Plaintiffs' Bar by law360 in 2020, further cementing its reputation in the legal community.

Investors are encouraged to exercise caution when selecting legal counsel, as many firms issuing similar notices may lack comparable experience or resources. The Rosen Law Firm stands out due to its extensive experience and successful track record in litigating securities class actions.

For updates, investors can follow Rosen Law Firm on LinkedIn, Twitter, or Facebook.